BackPerrigo Company plc Overview

Perrigo Company plc Other Current Liabilities

Perrigo Company plc's other current liabilities is $610M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$614.20M
9.39% YoYΔ $52.70M vs prior year quarter

Peer average / median

Loading

Perrigo Company plc Other Current Liabilities History

Loading

Perrigo Company plc vs. peers: Other Current Liabilities Comparison

Loading

Perrigo Company plc Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Perrigo Company plc (PRGO) FAQ

Perrigo Company plc's other current liabilities stands at $610M as of June 2026. That compares with $560M in the prior-year period — up 9.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Perrigo Company plc reported $610M in other current liabilities versus $560M a year earlier — a 9.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $560M in the prior-year period — up 9.4% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Perrigo Company plc's other current liabilities evolved across reporting periods, while the comparison chart places PRGO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current liabilities is commonly used to spot outliers. Perrigo Company plc's reading of $610M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.